{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:33881940", "kind": "science-record", "revision": 8, "content_hash": "sha256:30ccdace1b843f75b13128a4488210bbecebdadef15ad805fb41f62eede34350", "created_at": "2026-11-01T15:41:33Z", "updated_at": "2026-11-01T22:03:36Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "APLN: A potential novel biomarker for cervical cancer.", "doi": "10.1177/00368504211011341", "pmid": "33881940", "authors": ["Yusha Chen", "Xiaoqian Lin", "Jinwen Zheng", "Jiancui Chen", "Huifeng Xue", "Xiangqin Zheng"], "journal": "Science progress", "year": 2021, "abstract": "Apelin (APLN) is recently demonstrated a direct association with many malignant diseases. However, its effects on cervical cancer remain unclear. This study therefore aims to evaluate the association between APLN expression and cervical cancer using publicly available data from The Cancer Genome Atlas (TCGA). The Pearson χ2 test and Fish exact test, as well as logistic regression, were used to evaluate the relationship between clinicopathological factors in cervical cancer and the expression of APLN. Additionally, the Cox regression and Kaplan-Meier methods were conducted to analyze the Overall Survival (OS) of cervical cancer patients in TCGA. Finally, gene set enrichment analysis (GSEA) was performed to establish its biological functions. High expression of APLN in cervical cancer was significantly associated with a more advanced clinical stage (OR = 1.91 (1.21-3.05) for Stage II, Stage III, and Stage IV vs Stage I, p = 0.006). Additionally, it was associated with poor outcome after primary therapy (OR = 2.14 (1.03-4.59) for Progressive Disease (PD), Stable Disease (SD), and Partial Response (PR) vs Complete Remission (CR), p = 0.045) and high histologic grade (OR = 1.67 (1.03-2.72) for G3 and G4 vs G1 and G2, p = 0.037). Moreover, multivariate analysis showed that high expression of APLN was associated with a shorter OS. GSEA demonstrated that six KEGG pathways, including PPAR signaling, ECM-receptor interaction, focal adhesion, MAPK signaling, TGF-beta signaling, and Gap junction pathways were differentially enriched in the high expression APLN phenotype. The recent study suggests that APLN plays an important role in the progression of cervical cancer and might be a promising prognostic biomarker of the disease.", "claims": [{"id": "claim-method", "statement": "The expression levels of APLN in tumor and no-paired normal cervical tissue samples were compared using the Wilcoxon rank-sum test.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33881940", "locator": "sections[7] \"Statistical analysis\" paragraph 2", "quote": "The expression levels of APLN in tumor and no-paired normal cervical tissue samples were compared using the Wilcoxon rank-sum test."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The RNA-seq data (Workflow Type: HTSeq-Counts) and corresponding clinical information were downloaded from the TCGA-Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma datasets.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33881940", "locator": "sections[3] \"RNA-sequencing data preprocessing\" paragraph 2", "quote": "The RNA-seq data (Workflow Type: HTSeq-Counts) and corresponding clinical information were downloaded from the TCGA-Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma datasets."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:33881940"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE29570"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:group_comparison_wilcoxon", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE29570"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:group_comparison_wilcoxon"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:33881940", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1177/00368504211011341", "sha256": "sha256:3a89ca44d2026b74bc95797f1a6fc7325081f82d9e1dc7822ea1f604c62b355f", "bytes": 29617, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1177/00368504211011341", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC10454995", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE29570", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29570", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE29570", "version": null, "note": "The RNA-seq data (Workflow Type: HTSeq-Counts) and corresponding clinical information were downloaded from the TCGA-Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma datasets.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The RNA-seq data (Workflow Type: HTSeq-Counts) and corresponding clinical information were downloaded from the TCGA-Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma datasets.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM732034", "GSM732035", "GSM732037", "GSM732038", "GSM732039", "GSM732040", "GSM732041", "GSM732042", "GSM732044", "GSM732045", "GSM732046", "GSM732047", "GSM732049", "GSM732050", "GSM732051", "GSM732052", "GSM732054", "GSM732055", "GSM732056", "GSM732057", "GSM732059", "GSM732060", "GSM732061", "GSM732062", "GSM732065", "GSM732066", "GSM732067", "GSM732068", "GSM732069", "GSM732070", "GSM732071", "GSM732072", "GSM732073", "GSM732074", "GSM732075", "GSM732076", "GSM732077", "GSM732078", "GSM732079", "GSM732080", "GSM732081", "GSM732082", "GSM732083", "GSM732084", "GSM732085", "GSM732086", "GSM732087", "GSM732088", "GSM732089", "GSM732090", "GSM732091", "GSM732092", "GSM732093", "GSM732094", "GSM732095", "GSM732096", "GSM732097", "GSM732098", "GSM732099", "GSM732100", "GSM732101", "GSM732102"], "sample_count": 62, "group_sizes": null, "group_sizes_basis": null, "platform": "6244", "taxon": "Homo sapiens", "title": "The mtDNA Amerindian Haplogroup B2 enhances the risk for Cervical Cancer of HPV: de-regulation of mitochondrial genes may be involved.", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE7410", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7410", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE7410", "version": null, "note": "The RNA-seq data (Workflow Type: HTSeq-Counts) and corresponding clinical information were downloaded from the TCGA-Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma datasets.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The RNA-seq data (Workflow Type: HTSeq-Counts) and corresponding clinical information were downloaded from the TCGA-Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma datasets.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM178828", "GSM178829", "GSM178830", "GSM178831", "GSM178832", "GSM178833", "GSM178834", "GSM178835", "GSM178836", "GSM178837", "GSM178838", "GSM178839", "GSM178840", "GSM178841", "GSM178842", "GSM178843", "GSM178844", "GSM178845", "GSM178846", "GSM178847", "GSM178848", "GSM178849", "GSM178850", "GSM178851", "GSM178852", "GSM178853", "GSM178854", "GSM178855", "GSM178856", "GSM178857", "GSM178858", "GSM178859", "GSM178860", "GSM178861", "GSM178862", "GSM178863", "GSM178864", "GSM178865", "GSM178866", "GSM178867", "GSM178868", "GSM178869", "GSM178870", "GSM178871", "GSM178872"], "sample_count": 45, "group_sizes": null, "group_sizes_basis": null, "platform": "1708", "taxon": "Homo sapiens", "title": "Gene expression in early stage cervical cancer", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:33881940:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:f1da9e24849c7d57d0d29772640b3afa36f8772f87b625ba44413310ca267f43", "bytes": 1678, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[1]#table1-00368504211011341", "version": null, "note": "Association between APLN expression and clinicopathological features in the TCGA cohort.", "structure": {"pmcid": "PMC10454995", "section_index": 10, "section_title": "Association between the expression of APLN and clinicopathologic features", "row_count": 30, "column_count": 5}, "table": {"label": "Table 1.", "caption": "Association between APLN expression and clinicopathological features in the TCGA cohort.", "rows": [["Characters", "Level", "Low expression of APLN", "High expression of APLN", "p Value"], ["n", "", "152", "152", ""], ["N stage (%)", "N0", "75 (68.2%)", "58 (69.9%)", "0.924"], ["N1", "35 (31.8%)", "25 (30.1%)"], ["M stage (%)", "M0", "63 (96.9%)", "53 (86.9%)", "0.049a,b"], ["M1", "2 (3.1%)", "8 (13.1%)"], ["Clinical stage (%)", "Stage I", "92 (62.6%)", "70 (46.7%)", "0.006 a"], ["Stage II–IV", "55 (37.4%)", "80 (53.3%)"], ["Radiation therapy (%)", "No", "73 (48.0%)", "49 (32.2%)", "0.007 a"], ["Yes", "79 (52.0%)", "103 (67.8%)"], ["Primary therapy outcome (%)", "CR", "99 (88.4%)", "82 (78.1%)", "0.129 b"], ["PD", "8 (7.1%)", "14 (13.3%)"], ["PR", "4 (3.6%)", "4 (3.8%)"], ["SD", "1 (0.9%)", "5 (4.8%)"], ["Race (%)", "Asian", "15 (11.2%)", "5 (4.0%)", "0.054 b"], ["Black or African American", "12 (9.0%)", "18 (14.4%)"], ["White", "107 (79.9%)", "102 (81.6%)"], ["Histological type (%)", "Adenosquamous", "29 (19.1%)", "23 (15.1%)", "0.446"], ["Squamous cell carcinoma", "123 (80.9%)", "129 (84.9%)"], ["Histologic grade (%)", "G1", "11 (7.7%)", "7 (5.4%)", "0.120 b"], ["G2", "78 (54.5%)", "57 (44.2%)"], ["G3", "54 (37.8%)", "64 (49.6%)"], ["G4", "0 (0.0%)", "1 (0.8%)"], ["Menopause status (%)", "Peri", "15 (12.9%)", "10 (8.7%)", "0.230"], ["Post", "45 (38.8%)", "37 (32.2%)"], ["Pre", "56 (48.3%)", "68 (59.1%)"], ["PIK3CA status (%)", "Mut", "40 (27.8%)", "42 (29.6%)", "0.837"], ["WT", "104 (72.2%)", "100 (70.4%)"], ["Age (%)", "≤50", "91 (59.9%)", "95 (62.5%)", "0.724"], [">50", "61 (40.1%)", "57 (37.5%)"]], "row_count": 30, "column_count": 5, "numeric_cells": 71, "header_rows": 1, "locator": "section[10]/table-wrap[1]#table1-00368504211011341"}}, {"id": "asset:table:pmid:33881940:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:129043df5baa093cf9a30c36f70e3f77705eb686e3f892a19324f551bb4d0e21", "bytes": 902, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[2]#table2-00368504211011341", "version": null, "note": "APLN expression a associated with clinical pathological characteristic (logistic regression).", "structure": {"pmcid": "PMC10454995", "section_index": 10, "section_title": "Association between the expression of APLN and clinicopathologic features", "row_count": 8, "column_count": 4}, "table": {"label": "Table 2.", "caption": "APLN expression a associated with clinical pathological characteristic (logistic regression).", "rows": [["Characteristics", "Odds ratio in APLN expression", "Odds ratio (OR)", "p Value"], ["N stage (N1 vs N0)", "193", "0.92 (0.50–1.71)", "0.801"], ["M stage (M1 vs M0)", "126", "4.75 (1.13–32.42)", "0.055"], ["Clinical stage (stage II and stage III and stage IV vs stage I)", "297", "1.91 (1.21–3.05)", "0.006 b"], ["Histological type (squamous vs adenosquamous cell carcinoma)", "304", "1.32 (0.73–2.43)", "0.362"], ["Histologic grade (G3 and G4 vs G1 and G2)", "272", "1.67 (1.03–2.72)", "0.037 b"], ["PIK3CA status (Mut vs WT)", "286", "1.09 (0.65–1.83)", "0.737"], ["Primary therapy outcome (PD, SD, and PR vs CR)", "217", "2.14 (1.03–4.59)", "0.045 b"]], "row_count": 8, "column_count": 4, "numeric_cells": 21, "header_rows": 1, "locator": "section[10]/table-wrap[2]#table2-00368504211011341"}}, {"id": "asset:table:pmid:33881940:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:d953a20fdd18db180177a01b83bcee936d131c98d3de63082cec3cfc015388b5", "bytes": 1518, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#table3-00368504211011341", "version": null, "note": "Univariate and multivariate Cox proportional hazard analysis of APLN expression and OS for patients with cervical cancer in the TCGA cohort.", "structure": {"pmcid": "PMC10454995", "section_index": 11, "section_title": "Univariate and multivariate Cox analyses of survival", "row_count": 12, "column_count": 6}, "table": {"label": "Table 3.", "caption": "Univariate and multivariate Cox proportional hazard analysis of APLN expression and OS for patients with cervical cancer in the TCGA cohort.", "rows": [["Characteristics", "Total (N)", "HR (95% CI) univariate analysis", "p Value univariate analysis", "HR (95% CI) multivariate analysis", "p Value multivariate analysis"], ["N stage (N1 vs N0)", "193", "2.695 (1.358–5.349)", "0.005 a", "2.887 (1.206–6.912)", "0.017 a"], ["Clinical stage (stage II and stage III and stage IV vs stage I)", "297", "1.429 (0.896–2.280)", "0.134", "", ""], ["Radiation therapy (yes vs no)", "304", "1.153 (0.681–1.951)", "0.596", "", ""], ["Histological type (squamous vs adenosquamous cell carcinoma)", "304", "1.010 (0.530–1.926)", "0.976", "", ""], ["Menopause status (post vs pre and peri)", "231", "1.275 (0.744–2.185)", "0.376", "", ""], ["Histologic grade (G3 and G4 vs G1 and G2)", "272", "0.889 (0.527–1.502)", "0.661", "", ""], ["Age (>50 vs ≤50)", "304", "1.317 (0.825–2.101)", "0.248", "", ""], ["PIK3CA status (Mut vs WT)", "286", "1.011 (0.599–1.707)", "0.967", "", ""], ["Primary therapy outcome (PD, SD, and PR vs CR)", "217", "13.514 (7.250–25.189)", "<0.001 a", "7.877 (2.792–22.222)", "<0.001 a"], ["Race (Asian and Black or African American vs White)", "259", "0.841 (0.427–1.658)", "0.618", "", ""], ["APLN (high vs low)", "304", "1.942 (1.192–3.164)", "0.008 a", "3.428 (1.390–8.456)", "0.007 a"]], "row_count": 12, "column_count": 6, "numeric_cells": 42, "header_rows": 1, "locator": "section[11]/table-wrap[1]#table3-00368504211011341"}}, {"id": "asset:table:pmid:33881940:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:42bdf551fe5e5523728a041bdc3a1af79ac5a980eab08da59d5f56d9e45a0ae3", "bytes": 1513, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[2]#table4-00368504211011341", "version": null, "note": "Univariate and multivariate Cox proportional hazard analysis of APLN expression and PFS for patients with cervical cancer in the TCGA cohort.", "structure": {"pmcid": "PMC10454995", "section_index": 11, "section_title": "Univariate and multivariate Cox analyses of survival", "row_count": 12, "column_count": 6}, "table": {"label": "Table 4.", "caption": "Univariate and multivariate Cox proportional hazard analysis of APLN expression and PFS for patients with cervical cancer in the TCGA cohort.", "rows": [["Characteristics", "Total (N)", "HR (95% CI) univariate analysis", "p Value univariate analysis", "HR (95% CI) multivariate analysis", "p Value multivariate analysis"], ["N stage (N1 vs N0)", "193", "1.983 (0.986–3.990)", "0.055", "", ""], ["Clinical stage (stage II, stage III and stage IV vs stage I)", "297", "1.308 (0.821–2.084)", "0.258", "", ""], ["Radiation therapy (yes vs no)", "304", "1.288 (0.754–2.200)", "0.354", "", ""], ["Histological type (squamous vs adenosquamous cell carcinoma)", "304", "0.778 (0.433–1.397)", "0.400", "", ""], ["Menopause status (post vs pre and peri)", "231", "1.091 (0.640–1.861)", "0.749", "", ""], ["Histologic grade (G3 and G4 vs G1 and G2)", "272", "1.594 (0.967–2.627)", "0.067", "", ""], ["Age (>50 vs ≤50)", "304", "1.612 (1.012–2.568)", "0.044 a", "1.174 (0.688–2.002)", "0.557"], ["PIK3CA status (Mut vs WT)", "286", "0.994 (0.589–1.679)", "0.983", "", ""], ["Primary therapy outcome (PD, SD, and PR vs CR)", "217", "7.907 (4.631–13.500)", "<0.001 a", "7.461 (4.342–12.821)", "<0.001 a"], ["Race (Asian and Black or African American vs White)", "259", "1.066 (0.553–2.057)", "0.848", "", ""], ["APLN (high vs low)", "304", "1.683 (1.045–2.709)", "0.032 a", "1.741 (1.010–2.999)", "0.046 a"]], "row_count": 12, "column_count": 6, "numeric_cells": 42, "header_rows": 1, "locator": "section[11]/table-wrap[2]#table4-00368504211011341"}}, {"id": "asset:table:pmid:33881940:5", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:8d52a0bbcce95fbf63a97f605c4bf854584918a5b2f16e16255bebecb742559b", "bytes": 1517, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[3]#table5-00368504211011341", "version": null, "note": "Univariate and multivariate Cox proportional hazard analysis of APLN expression and DSS for patients with cervical cancer in the TCGA cohort.", "structure": {"pmcid": "PMC10454995", "section_index": 11, "section_title": "Univariate and multivariate Cox analyses of survival", "row_count": 12, "column_count": 6}, "table": {"label": "Table 5.", "caption": "Univariate and multivariate Cox proportional hazard analysis of APLN expression and DSS for patients with cervical cancer in the TCGA cohort.", "rows": [["Characteristics", "Total (N)", "HR (95% CI) univariate analysis", "p Value univariate analysis", "HR (95% CI) multivariate analysis", "p Value multivariate analysis"], ["N stage (N1 vs N0)", "191", "3.303 (1.446–7.541)", "0.005 a", "2.970 (1.187–7.430)", "0.02 a"], ["Clinical stage (stage II, stage III and stage IV vs stage I)", "293", "1.608 (0.941–2.749)", "0.082", "", ""], ["Radiation therapy (yes vs no)", "300", "1.772 (0.891–3.522)", "0.103", "", ""], ["Histological type (squamous vs adenosquamous cell carcinoma)", "300", "0.956 (0.467–1.958)", "0.901", "", ""], ["Menopause status (post vs pre and peri)", "228", "1.233 (0.678–2.243)", "0.493", "", ""], ["Histologic grade (G3 and G4 vs G1 and G2)", "269", "0.955 (0.530–1.720)", "0.877", "", ""], ["Age (>50 vs ≤50)", "300", "1.333 (0.780–2.278)", "0.292", "", ""], ["PIK3CA status (Mut vs WT)", "282", "1.097 (0.606–1.989)", "0.759", "", ""], ["Primary therapy outcome (PD, SD, and PR vs CR)", "217", "16.934 (8.629–33.235)", "<0.001 a", "10.497 (3.470–31.753)", "<0.001 a"], ["Race (Asian and Black or African American vs White)", "257", "0.770 (0.344–1.724)", "0.526", "", ""], ["APLN (high vs low)", "300", "2.178 (1.236–3.838)", "0.007 a", "5.134 (1.854–14.216)", "0.002 a"]], "row_count": 12, "column_count": 6, "numeric_cells": 42, "header_rows": 1, "locator": "section[11]/table-wrap[3]#table5-00368504211011341"}}, {"id": "asset:table:pmid:33881940:6", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:8fc1d098cf23e5bac943dde5a70caee06727b21b92dbd19ebbe926f1ff8526fe", "bytes": 576, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#table6-00368504211011341", "version": null, "note": "KEGG pathways enriched in the high APLN expression group using GSEA.", "structure": {"pmcid": "PMC10454995", "section_index": 12, "section_title": "APLN-related signaling pathways based on gene set enrichment analysis (GSEA)", "row_count": 7, "column_count": 4}, "table": {"label": "Table 6.", "caption": "KEGG pathways enriched in the high APLN expression group using GSEA.", "rows": [["Name", "NES", "p. adjust", "FDR"], ["KEGG_ECM_RECEPTOR_INTERACTION", "2.299", "0.017", "0.012"], ["KEGG_FOCAL_ADHESION", "2.216", "0.017", "0.012"], ["KEGG_TGF_BETA_SIGNALING", "1.976", "0.017", "0.012"], ["KEGG_MAPK_SIGNALING", "1.951", "0.017", "0.012"], ["KEGG_PPAR_SIGNALING", "1.712", "0.03", "0.021"], ["KEGG_CALCIUM_SIGNALING", "1.525", "0.028", "0.020"]], "row_count": 7, "column_count": 4, "numeric_cells": 18, "header_rows": 1, "locator": "section[12]/table-wrap[1]#table6-00368504211011341"}}], "gaps": ["asset:data:geo:GSE29570 not downloaded", "asset:data:geo:GSE29570 licence not read", "asset:data:geo:GSE7410 not downloaded", "asset:data:geo:GSE7410 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The expression levels of APLN in tumor and no-paired normal cervical tissue samples were compared using the Wilcoxon rank-sum test."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Cox regression"}}, {"id": "method-4", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-5", "family": "regression_modelling", "specific": "logistic", "label": "Regression modelling", "dsl_operations": ["glm_logit_fit"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["predictors_and_outcome"], "evidence": {"score": 0.7, "band": "medium", "quote": "logistic regression"}}, {"id": "method-6", "family": "contingency_analysis", "specific": "chi_square", "label": "Categorical (contingency table) analysis", "dsl_operations": ["chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.7, "band": "medium", "quote": "χ2"}}], "targets": [], "gaps": ["method.group_comparison_wilcoxon"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE7410", "GSE29570"], "resolved_accessions": ["GSE7410", "GSE29570"], "statements": ["The RNA-seq data (Workflow Type: HTSeq-Counts) and corresponding clinical information were downloaded from the TCGA-Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma datasets."], "basis": "The paper names GSE7410, GSE29570 in NCBI-GEO (Gene Expression Omnibus) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:33881940", "data:geo:GSE29570", "asset:table:pmid:33881940:1", "asset:table:pmid:33881940:2", "asset:table:pmid:33881940:3", "asset:table:pmid:33881940:4", "asset:table:pmid:33881940:5", "asset:table:pmid:33881940:6"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "group_comparison_wilcoxon", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE29570"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:29:19Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 3, "usage": {"prompt_tokens": 23198, "completion_tokens": 1440, "cached_tokens": 7936}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:33881940", "type": "paper", "label": "pmid:33881940"}, {"id": "source:pmid:33881940", "type": "manuscript", "label": "PMID 33881940 full text"}, {"id": "data:geo:GSE29570", "type": "dataset", "label": "GEO GSE29570"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:33881940", "type": "paper", "label": "pmid:33881940"}, {"id": "source:pmid:33881940", "type": "manuscript", "label": "PMID 33881940 full text"}, {"id": "data:geo:GSE29570", "type": "dataset", "label": "GEO GSE29570"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-33881940", "type": "extraction", "used": ["source:pmid:33881940"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE29570", "type": "accession_resolution", "used": ["data:geo:GSE29570"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:33881940", "parent_hash": "sha256:7c578271ce9857da236b1e7e16cac368516eb989effdb79b6414dd6f8098f610", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE29570 licence not read", "asset:data:geo:GSE29570 not downloaded", "asset:data:geo:GSE7410 licence not read", "asset:data:geo:GSE7410 not downloaded", "execution.not_run", "method.group_comparison_wilcoxon", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:run_analysis blocked on method:group_comparison_wilcoxon"], "assays": [{"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["The expression levels of APLN in tumor and no-paired normal cervical tissue samples were compared using the Wilcoxon rank-sum test."], "order_basis": "analysis_only", "id": "assay:1"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T02:45:14+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}